Increasing clarity on bone loss associated with antiretroviral initiation
- PMID: 21606527
- DOI: 10.1093/infdis/jir184
Increasing clarity on bone loss associated with antiretroviral initiation
Comment on
-
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.J Infect Dis. 2011 Jun 15;203(12):1791-801. doi: 10.1093/infdis/jir188. J Infect Dis. 2011. PMID: 21606537 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
